i wanted to take this opportunity to say thank you personally for all the wonderful messages of support and for your understanding once i ve been recovering from surgery. it has been an incredibly tough couple of months for our entire family, but i ve had a fantastic medical team who have taken great care of me for which i am so grateful. in january i underwent major abdominal surgery in london and at the time it was thought that my condition was non-cancerous. the surgery was successful. tests after the operation found cancer had been present. my medical team therefore at vised i should undergo preventive chemotherapy and i m in the early stages of that treatment. this, of course, came as a huge shock, and william and i have been doing everything we can to process and manage this privately for the sake of our young family. as you can fachimagine this has taken time. for me to recover from major surgery to start my treatment but most importantly it has taken us time to expl
been diagnosed with cancer and is postponing public duties. he left the hospital a week ago after treatment for an enlarged prostate. joining us is nbc s molly hunter. i understand the palace has just released a statement. what are they saying? chris, that s right. we just got the statement. i m just reading it for the first time as well. the big thing to understand, as you know, we covered the king s health scare last week which was really presented as a routine procedure. he was only in the hospital for three nights. he was in the london clinic right here in central london. right now we have the statement from buckingham palace. it says during the king s recent hospital procedure for benign prostate enlargement of owes that s what we knew. we knew he had gone into the hospital for what he and the palace called a routine procedure. a separate issue of concern was noted. subsequent diagnostic tests have identified a form of cancer. this is coming directly from buckingham pa
Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine.
Moderna, Inc.: Moderna And Merck Announce mRNA-4157 In Combination with Keytruda Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resect finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.